user

Factors Influencing the Prescribing Preferences of Physicians for Drug-Naive Patients with Type 2 Diabetes Mellitus in the Real-World Setting in Japan: Insight from a Web Survey

被引：0
|
作者：
Hiroki Murayama
Kota Imai
Masato Odawara
机构：
[1] Novartis Pharma K.K,Medical Division
[2] Tokyo Medical University,Department of Diabetes, Endocrinology, Metabolism, and Rheumatology
来源：
Diabetes Therapy | 2018年 / 9卷
关键词：
Dipeptidyl peptidase-4 inhibitor; Diabetes nonspecialist; Diabetes specialist; Drug-naive; Japan; First line; Metformin; Online survey; Oral antidiabetes drugs; Treatment choices; Type 2 diabetes mellitus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1185 / 1199
页数：14
相关论文
共 50 条
  • [31] Effectiveness of vildagliptin as add-on to metformin monotherapy among uncontrolled type 2 diabetes mellitus patients in a real-world setting
    Melzer Cohen, Cheli
    Davis, Carla
    Shalev, Varda
    Chodick, Gabriel
    JOURNAL OF DIABETES, 2018, 10 (01) : 68 - 72
  • [32] Real-World Use of Once-Weekly Semaglutide in Thai Patients With Type 2 Diabetes Mellitus in a Private Hospital Setting
    Thewjitcharoen, Yotsapon
    Yenseung, Nalin
    Butadej, Siriwan
    Nakasatien, Soontaree
    Chotwanvirat, Phawinpon
    Chatchomchuan, Waralee
    Wanothayaroj, Ekgaluck
    Krittiyawong, Sirinate
    Himathongkam, Thep
    JOURNAL OF THE ASEAN FEDERATION OF ENDOCRINE SOCIETIES, 2023, 38 (01): : 21 - 28
  • [33] Impact of atherosclerotic cardiovascular disease on healthcare resource utilization and costs in patients with type 2 diabetes mellitus in a real-world setting
    Wayne Weng
    Ye Tian
    Sheldon X. Kong
    Rahul Ganguly
    Malene Hersloev
    Jason Brett
    Todd Hobbs
    Clinical Diabetes and Endocrinology, 6 (1):
  • [34] Short-term outcomes of patients with Type 2 diabetes mellitus treated with canagliflozin compared with sitagliptin in a real-world setting
    Shao, Yan Li
    Yee, Kuan Hao
    Koh, Seow Ken
    Wong, Yip Fong
    Yeoh, Lee Ying
    Low, Serena
    Sum, Chee Fang
    SINGAPORE MEDICAL JOURNAL, 2018, 59 (05) : 251 - 256
  • [35] Eligibility and Awareness Regarding Metabolic Surgery in Patients With Type 2 Diabetes Mellitus in the Real-World Clinical Setting; Estimate of Possible Diabetes Remission
    Koliaki, Chrysi
    Tzeravini, Evangelia
    Papachristoforou, Eleftheria
    Severi, Ioanna
    El Deik, Elina
    Karaolia, Melina
    Noutsou, Marina
    Thanopoulou, Anastasia
    Kountouri, Aikaterini
    Balampanis, Konstantinos
    Lambadiari, Vaia
    Tentolouris, Nicholas
    Kokkinos, Alexander
    FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [36] Probiotic Supplementation (Vibact DS) in Patients with Type 2 Diabetes Mellitus: Real-world Experience from India
    Gupta, Sunil
    Kamat, Tejas
    Chawla, Rajeev
    Abhyankar, Mahesh V.
    Revankar, Santosh
    Walia, Silki
    JOURNAL OF DIABETOLOGY, 2022, 13 (01) : 101 - 105
  • [37] Genotypic and Phenotypic Factors Influencing Drug Response in Mexican Patients With Type 2 Diabetes Mellitus
    Sanchez-Ibarra, Hector E.
    Reyes-Cortes, Luisa M.
    Jiang, Xian-Li
    Luna-Aguirre, Claudia M.
    Aguirre-Trevino, Dionicio
    Morales-Alvarado, Ivan A.
    Leon-Cachon, Rafael B.
    Lavalle-Gonzalez, Fernando
    Morcos, Faruck
    Barrera-Saldana, Hugo A.
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [38] Incidence and factors associated of early non-response in first-treatment and drug-naive patients with schizophrenia: a real-world study
    Zhang, Lin
    Bai, Aohan
    Tang, Zhongyu
    Liu, Xuebing
    Li, Yi
    Ma, Jun
    FRONTIERS IN PSYCHIATRY, 2023, 14
  • [39] Real-World Effectiveness of Sitagliptin as Add-On Therapy in Patients With Type 2 Diabetes Mellitus
    Chen, Tse-Ying
    Hsieh, Ching-Jung
    POSTGRADUATE MEDICINE, 2014, 126 (03) : 205 - 215
  • [40] Metformin dosage patterns in type 2 diabetes patients in a real-world setting in the United States
    Mahabaleshwarkar, Rohan
    DeSantis, Andrea
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 172
12345